What are the common dosing combinations for compounded estradiol and testosterone and how should they be ordered?

Common Dosing Combinations for Compounded Estradiol and Testosterone

Compounded "bioidentical" testosterone therapy cannot be recommended unless an FDA-approved preparation is unavailable, and when used, dosing must maintain testosterone concentrations in the physiologic premenopausal range (approximately 15-70 ng/dL total testosterone). 1

Critical Guideline Framework

The 2019 Global Consensus Statement explicitly advises against compounded bioidentical testosterone due to lack of efficacy and safety data 1. Similarly, the 2015 Endocrine Society guidelines recommend against custom-compounded hormones and favor FDA-approved preparations 2. However, both acknowledge that when approved female-specific formulations are unavailable, off-label use of male formulations or compounded products may be reasonable under strict conditions.

When Compounding May Be Considered

If you must use compounded preparations:

• The compounding pharmacy must comply with Active Pharmaceutical Ingredient purity standards and Good Manufacturing Practice 1
• Dosing must achieve physiologic premenopausal testosterone ranges only
• Preparations resulting in supraphysiologic testosterone concentrations (including pellets and injections) are explicitly not recommended 1

Typical Dosing Ranges (Based on FDA-Approved Male Formulations Adapted for Women)

Testosterone Component:

• Starting dose: 5-10 mg daily (transdermal)
• Target serum total testosterone: 15-70 ng/dL (premenopausal physiologic range)
• Maximum: Should not exceed doses that produce supraphysiologic levels 1

For reference, FDA-approved male testosterone gel 1.62% delivers 20.25-81 mg daily 3, which is far too high for women. Female dosing requires approximately 1/4 to 1/10 of male doses.

Estradiol Component:

When combining with testosterone in postmenopausal women:

• Transdermal estradiol: 0.025-0.1 mg/day (patch or gel)
• Oral micronized estradiol: 0.5-2 mg daily
• Transdermal preparations are preferable to avoid first-pass hepatic effects 2

Common Compounded Combinations

Option 1: Transdermal Cream/Gel

• Estradiol 0.5-1 mg + Testosterone 2-5 mg per gram
• Apply 0.5-1 gram daily to shoulders/upper arms
• This provides estradiol 0.5-1 mg and testosterone 2-5 mg daily

Option 2: Transdermal Cream/Gel (Higher Estradiol)

• Estradiol 1-2 mg + Testosterone 5-10 mg per gram
• Apply 0.5-1 gram daily
• Provides estradiol 1-2 mg and testosterone 5-10 mg daily

How to Order from Compounding Pharmacy

Prescription format:

Rx: Estradiol 1 mg + Testosterone 5 mg per gram
Transdermal cream/gel
Dispense: 30 grams
Sig: Apply 0.5-1 gram to shoulders and upper arms daily

Specify:

• Vehicle type (cream, gel, or ointment base)
• Total quantity needed (typically 30-60 grams for monthly supply)
• Application site (shoulders and upper arms for testosterone per FDA guidance) 3

Mandatory Monitoring Protocol

Before initiating:

• Baseline total testosterone level (morning draw) 1

Follow-up schedule:

• Repeat testosterone at 3-6 weeks after initiation 1
• Serum testosterone every 6 months to screen for overuse and assess for androgen excess 1
• Discontinue if no benefit by 6 months 1

Critical Pitfalls to Avoid

1. Never use pellets or injections - these produce supraphysiologic levels 1
2. Do not apply to abdomen, genitals, chest, or axillae - FDA guidance specifies shoulders and upper arms only 3
3. Avoid doses exceeding physiologic premenopausal ranges - this increases adverse effects without additional benefit
4. Research shows testosterone can induce insulin resistance and adverse lipid profiles (decreased HDL) even at therapeutic doses 4
5. Patients must wash hands immediately after application and cover application sites to prevent transfer 3

Evidence-Based Indication

The only evidence-based indication for testosterone in women is hypogonadal sexual desire disorder (HSDD) in postmenopausal women after formal biopsychosocial assessment 1. There is no established indication for combined estradiol-testosterone in other contexts beyond this specific diagnosis.

Practical Consideration

Given the lack of safety data beyond 24 months 1 and the explicit recommendation against compounded products 1, 2, strongly consider FDA-approved estradiol products (patches, gels, tablets) combined with low-dose FDA-approved testosterone gel (using 1/4 to 1/10 of male dosing) rather than compounded combinations. This approach provides better quality control and regulatory oversight.